Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism

Stroke

Volumn 40, Issue 5, 2009, Pages 1627-1632

  Kim, Beom Joon ^a   Lee, Seung Hoon ^a   Ryu, Wi Sun ^a   Kang, Bong Su ^a   Kim, Chi Kyung ^a   Yoon, Byung Woo ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Cholesterol; Hemorrhagic; Ischemic stroke; Low density lipoprotein cholesterol; Neurovascular unit; Transformation

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EMBOLISM; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THROMBOSIS; ATHEROSCLEROSIS; BLOOD; BRAIN EMBOLISM; BRAIN ISCHEMIA; DISEASE COURSE; MIDDLE AGED; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOLOGY; STATISTICAL MODEL; STROKE;

AGED; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CHOLESTEROL; CHOLESTEROL, LDL; DISEASE PROGRESSION; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; INTRACRANIAL THROMBOSIS; LIPOPROTEINS, LDL; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STROKE; TRIGLYCERIDES;

EID: 65549117287     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.539643     Document Type: Article

References (37)

1. Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, Fujishima M, Omae T. Hemorrhagic transformation in cerebral embolism. Stroke. 1989;20:598-603.
2. Larrue V, von Kummer R, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European Australasian acute stroke study (ECASS II). Stroke. 2001;32: 438-441.
3. Dzialowski I, Pexman JHW, Barber PA, Demchuk AM, Buchan AM, Hill MD, on behalf of the CI. Asymptomatic hemorrhage after thrombolysis may not be benign: Prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke. 2007;38:75-79.
4. Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol. 2003;28:229-244.
5. Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Davalos A, Hamann GF. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke. 2003;34:40-46.
6. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology. 2002;59:669-674.
7. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European cooperative acute stroke study. Stroke. 1997;28:957-960.
8. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363: 768-774.
9. Rodriguez-Yanez M, Castellanos M, Blanco M, Millan M, Nombela F, Sobrino T, Lizasoain I, Leira R, Serena J, Davalos A, Castillo J. Micro-and macroalbuminuria predict hemorrhagic transformation in acute ische-mic stroke. Neurology. 2006;67:1172-1177.
10. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320: 904-910.
11. Reed DM. The paradox of high risk of stroke in population with low risk of coronary heart disease. Am J Epidemiol. 1990;131:579-588.
12. Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
13. Lee S-H, Kang B-S, Kim N, Roh J-K. Does microbleed predict hemor-rhagic transformation after acute atherothrombotic or cardioembolic stroke? J Neurol Neurosurg Psychiatry. 2008:79;913-916.
14. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35-41.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
16. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, Lechner H. White matter signal abnormalities in normal individuals: Correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke. 1988;19:1285-1288.
17. Lee SH, Kwon SJ, Kim KS, Yoon BW, Roh JK. Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol. 2004;251:1183-1189.
18. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, Palmerini F, Biagini S, Comi G, Previdi P, Silvestrelli G. Early hemorrhagic transformation of brain infarction: Rate, predictive factors, and influence on clinical outcome: Results of a prospective multicenter study. Stroke. 2008;39:2249-2256.
19. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the Honolulu heart program. Stroke. 1989;20:1460-1465.
20. Giroud M, Creisson E, Fayolle H, Andre N, Becker F, Martin D, Dumas R. Risk factors for primary cerebral hemorrhage: A population-based study-the stroke registry of Dijon. Neuroepidemiology. 1995;14:20-26.
21. Suh I, Jee SH, Kim HC, Nam CM, Kim IS, Appel LJ. Low serum cholesterol and haemorrhagic stroke in men: Korea medical insurance corporation study. Lancet. 2001;357:922-925.
22. Inagawa T. Risk factors for primary intracerebral hemorrhage in patients in Izumo City, Japan. Neurosurg Rev. 2007;30:225-234.
23. Collins R, Armitage J, Parish S, Sleight P, Peto R. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757-767.
24. Thrift A, McNeil J, Donnan G. Reduced frequency of high cholesterol levels among patients with intracerebral haemorrhage. J Clin Neurosci. 2002;9:376-380.
25. Asahi M, Rammohan R, Sumii T, Xiaoying W, Pauw R, Weissig V, Torchilin V, Lo EH. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activater-induced hemorrhage after focal embolic stroke. J Cereb Blood Flow Metab. 2003;23:895-899.
26. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971;30:536-550.
27. Lee S-H, Bae H-J, Yoon B-W, Kim H, Kim D-E, Roh J-K. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: Analysis of risk factors for multifocal signal loss lesions. Stroke. 2002;33:2845-2849.
28. Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, Buck B, Ali L, Restrepo L, Vinuela F, Duckwiler G, Jahan R, Razinia T, Ovbiagele B. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology. 2007;68: 737-742.
29. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: A population-based study of incidence and risk factors. Stroke. 1999;30:2513-2516.
30. Mark KS, Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol. 2002;282:H1485-H1494.
31. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 1994;25:202-211.
32. Kondo T, Kinouchi H, Kawase M, Yoshimoto T. Astroglial cells inhibit the increasing permeability of brain endothelial cell monolayer following hypoxia/reoxygenation. Neurosci Lett. 1996;208:101-104.
33. Chaves C, Hreib K, Allam G, Liberman RF, Lee G, Caplan LR. Patterns of cerebral perfusion in patients with asymptomatic internal carotid artery disease. Cerebrovasc Dis. 2006;22:396-401.
34. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Babikian VL, Lefkowitz D, Goldman RS, Armon C, Hsu CY, Goodin DS. Assessment: Transcranial Doppler ultrasonography: Report of the therapeutics and technology assessment subcommittee of the Am Academy of Neurology. Neurology. 2004;62:1468-1481.
35. Jacobs DR Jr, Muldoon MF, Rastam L. Invited commentary: Low blood cholesterol, nonillness mortality, and other nonatherosclerotic disease mortality: A search for causes and confounders. Am J Epidemiol. 1995; 141:518-522.
36. Mendez I, Hachinski V, Wolfe B. Serum lipids after stroke. Neurology. 1987;37:507-511.
37. Korea Food and Drug Administration. Food & drug statistical yearbook: 2007. Seoul: Korea Food and Drug Administration; 2008.